Navigation Links
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014
Date:8/24/2014

as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

Regeneron Forward-Looking Statements
This news release includes forward-looking statements that involve risks and uncertainties relating to future events and the future performance of Regeneron, and actual events or results may differ materially from these forward-looking statements.  Words such as "anticipate," "expect," "intend," "plan," "believe," "seek," "estimate," variations of such words, and similar expressions are intended to identify such forward-looking statements, although not all forward-looking statements contain these identifying words.  These statements concern, and these risks and uncertainties include, among others, the nature, timing, and possible success and therapeutic applications of Regeneron's products, product candidates, and research and clinical programs now underway or planned, including without limitation alirocumab; unforeseen safety issues resulting from the administration of products and product candidates in patients, including serious complications or side effects in connection with the use of Regeneron's product candidates in clinical trials, such as the ODYSSEY global trial program evaluating alirocumab; the likelihood and timing of possible regulatory approval and commercial launch of Regeneron's late-stage product candidates, including without limitation alirocumab; determinations by regulatory and administrative governmental authorities which may delay or restrict Regeneron's ability to continue to develop or commercialize Regeneron's products and product candidates; competing drugs and product candidates that may be superior to Regeneron's products and product candidates; uncertainty of market acceptance and commercial success of Regeneron's products and product candidates; the ability of Regeneron to manufacture and manage supply chains for multiple products an
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Regeneron Announces Upcoming 2014 Investor Conference Presentations
2. Regeneron Reports Second Quarter 2014 Financial and Operating Results
3. Regeneron and Sanofi Report Positive Top-Line Results from Nine Phase 3 Trials of Alirocumab in People with Hypercholesterolemia
4. Regeneron and Bayer to Develop New Treatment Option for Wet Age-Related Macular Degeneration
5. Regeneron Announces Upcoming 2013 Investor Conference Presentation
6. Sanofi and Regenerons Dupilumab Named "Clinical Advance of the Year" by Scrip Intelligence
7. Sanofi and Regeneron Report Positive Results with Sarilumab in First Phase 3 Rheumatoid Arthritis Registration Trial
8. Regeneron Reports Third Quarter 2013 Financial and Operating Results
9. Regeneron Announces Appointment of Robert E. Landry as Senior Vice President, Finance and Chief Financial Officer
10. Regenerons Eylea Now Captures One-Quarter Of Wet AMD Patient Share, Surpassing Share Of Roche/Genentechs Lucentis
11. Quarterly Financial Results and Development Program Updates - Research Report on Regeneron, DaVita, Celldex, Isis, and VIVUS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  IRIDEX Corporation (NASDAQ: ... quarter and full year 2014 financial results after the market ... with the release, the Company will host a conference call ... on Thursday, March 5, 2015 to discuss ... Interested parties may access the live conference call via ...
(Date:2/26/2015)... , Feb. 26, 2015 Legislation passed ... a pharmacy provision to help prevent inappropriate prescriptions in ... Protecting the Integrity of Medicare Act (PIMA) of ... Chairman Kevin Brady (R-TX) and Ranking Member ... prescription drug abuse epidemic and implement the right policies, ...
(Date:2/26/2015)... and Markets ( http://www.researchandmarkets.com/research/2vn6hh/radiation_therapy ) has announced ... Global Strategic Business Report" report to their offering. ... for Radiation Therapy Equipment in US$ Million by the ... Radiation Therapy Simulator. The report provides separate comprehensive analytics ... Japan , Europe , ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
... committed to improving the health of its patients, workforce ... medical equipment to more eco-friendly alternatives that are free ... plastics that have been shown to harm human and ... purchase IV solution bags that are 100 percent PVC ...
... SHENZHEN, China, Jan. 19, 2012 /PRNewswire-Asia-FirstCall/ -- Mindray Medical ... developer, manufacturer and marketer of medical devices worldwide, today ... 2012 to be held between January 23 and 26 ... Health is the most important annual medical exhibition in ...
Cached Medicine Technology:Kaiser Permanente Moves to Green Medical Supplies by Converting to Eco-Friendly IV Equipment 2Kaiser Permanente Moves to Green Medical Supplies by Converting to Eco-Friendly IV Equipment 3Mindray Medical to Exhibit at Arab Health 2012 in Dubai from January 23-26 2
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 ... Devices (IPD), has introduced miniature, wire bondable, silicon ESD ... Power LED markets. The ESD88NP and ... currents away from sensitive LED and IC products. ... Multilayer Varistors (MLV). All devices meet the requirements ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 Just a ... air for those suffering from Sjögren’s Syndrome after a ... by researchers at the University of Buffalo and Immco ... of research was to develop a new diagnostic ... the presence of new autoantibodies. Researchers aimed to develop ...
(Date:2/27/2015)... 27, 2015 Today, February 27th, is "Shine ... , along with LXR Organics and Living ... Campaign to raise awareness and promote prevention, rescue and restoration ... by the END IT Coalition, slavery is the 2nd largest ... exists in 167 countries around the world. Slavery includes bonded ...
(Date:2/27/2015)... February 27, 2015 Clinovo, a leading ... validated Electronic Data Capture (EDC) at the CALBIO2015 ... March 2nd and March 3rd at Booth # 141. ... and DIY CRF and edit-check builder allowing Clinical Trials ... matter of days, without any programming experience. Clinovo’s new ...
(Date:2/27/2015)... Laguna Hills, CA (PRWEB) February 27, 2015 ... has been chosen as their Sage ERP Document Management ... ERP, Sage 300 ERP, Sage CRM and other complimentary ... ADSS Global have worked side-by-side for many years to ... their Sage ERP applications. , “We are thrilled ...
Breaking Medicine News(10 mins):Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 2Health News:OnChip Introduces New Series of Space Saving Bare-die Zener Diodes for Transient Voltage Suppression 3Health News:Breakthrough Blood Test for Early Detection of Sjögren’s Syndrome Now Available 2Health News:KAJ Brothers Join the Campaign to 'End It - Shine A Light On Slavery' 2Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Altec Announces 2014 Sage ERP Document Management Partner of the Year Award Recipient 2
... published in the March issue of the Journal ... lung transplantation should be used with caution in patients ... associated with high rates of mortality after one year ... been the gold-standard treatment for a variety of end-stage ...
... Help Peripheral Arterial Disease (PAD) Patients With Critical ... Attempts to treat critical limb ischemia in ... are still thwarted by restenosis (the re-narrowing of ... stenting), the need for repeat treatments and the ...
... Inc., a provider of nanoproteomic analysis systems to life ... protein analysis system to The University of Manchester,s Stem ... Whetton. Professor Whetton is a pioneer in the use ... normal and leukaemic stem cells. The Cell Biosciences system ...
... enhance patient satisfaction, however, study finds , , TUESDAY, March ... system could help ease the increasing workload faced by ... such a system in the Kaiser Permanente health plan. ... patients to communicate via secure e-mails instead of a ...
... Detroit Piston player Rodney Stuckey is,rallying Detroit ... of a new,national campaign called Get Fit By Finals. The ... milk?" Body By Milk(R) Campaign and NBA FIT, the,NBA,s comprehensive ... and adults through fitness and nutrition. , ...
... 10 Swissray International, Inc. announced that they have ... Veterans Affairs to sell their complete line of digital ... Department of Defense, VA Medical Centers or Government Agencies ... the contract could be effective until December, 2016.Swissray has ...
Cached Medicine News:Health News:Journal of American College of Surgeons finds lung transplantation should be used in older patients 2Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 2Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 3Health News:Promising Three-year Data: Saving Limbs With Drug-Eluting Stents 4Health News:Cell Biosciences Announces First UK System Sale 2Health News:Electronic Communication May Be Boon to Doctors' Time 2Health News:got milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Remus Robinson Middle School 2Health News:got milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Remus Robinson Middle School 3Health News:got milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Remus Robinson Middle School 4Health News:got milk?(R) and the NBA Showcase New National Teen Health and Fitness Initiative at Remus Robinson Middle School 5Health News:Swissray Awarded US Government Contract 2
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
... Scrub swabsticks is formulated with ... to prevent dryness. It contains ... to 0.75% available iodine. Povidone-Iodine ... surface pathogens, including gram-negative and ...
Medicine Products: